Related references
Note: Only part of the references are listed.Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: An open-label extension trial
Elizabeth A. Thiele et al.
EPILEPSIA (2022)
Add-On Cannabidiol Treatment for Drug-Resistant Seizures in Tuberous Sclerosis Complex A Placebo-Controlled Randomized Clinical Trial
Elizabeth A. Thiele et al.
JAMA NEUROLOGY (2021)
Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: Analysis from two randomized controlled trials
Michael Privitera et al.
EPILEPSIA (2021)
Time to onset of cannabidiol treatment effects in Dravet syndrome: Analysis from two randomized controlled trials
Jennifer Madan Cohen et al.
EPILEPSIA (2021)
Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome A Randomized Clinical Trial
Ian Miller et al.
JAMA NEUROLOGY (2020)
Autism and Epilepsy in Patients With Tuberous Sclerosis Complex
Nicola Specchio et al.
FRONTIERS IN NEUROLOGY (2020)
Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
Paolo Curatolo et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Epilepsy treatment patterns among patients with tuberous sclerosis complex
Jinlin Song et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele et al.
LANCET (2018)
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A clinical update on tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)
Petrus J. de Vries et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2018)
TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study
Petrus J. de Vries et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
Lesley Taylor et al.
CNS DRUGS (2018)
Causes of mortality in individuals with tuberous sclerosis complex
Sam Amin et al.
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2017)
Interdependence of clinical factors predicting cognition in children with tuberous sclerosis complex
I. E. Overwater et al.
JOURNAL OF NEUROLOGY (2017)
Influence of seizures on early development in tuberous sclerosis complex
Jamie K. Capal et al.
EPILEPSY & BEHAVIOR (2017)
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Orrin Devinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients
John C. Kingswood et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Systemic disease manifestations associated with epilepsy in tuberous sclerosis complex
Anna Jeong et al.
EPILEPSIA (2016)
Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study
Jacqueline A. French et al.
LANCET (2016)
Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs
Iris E. Overwater et al.
EPILEPSIA (2015)
Everolimus Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex
Darcy A. Krueger et al.
ANNALS OF NEUROLOGY (2013)
The natural history of epilepsy in tuberous sclerosis complex
Catherine J. Chu-Shore et al.
EPILEPSIA (2010)
Risk factors in sudden death in epilepsy (SUDEP): The quest for mechanisms
Lina Nashef et al.
EPILEPSIA (2007)
The tuberous sclerosis complex
Peter B. Crino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytornas:: Biallelic inactivation of TSC1 or TSC2 leads to rnTOR activation
JA Chan et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Vigabatrin for tuberous sclerosis complex
P Curatolo et al.
BRAIN & DEVELOPMENT (2001)
Share Paper
